These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 8729894

  • 21. Criteria for use of colfosceril (Exosurf) in neonates.
    Bhatt-Mehta V, Schumacher RE.
    Clin Pharm; 1992 Apr; 11(4):355-7. PubMed ID: 1563234
    [No Abstract] [Full Text] [Related]

  • 22. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome.
    Soll R, Ozek E.
    Cochrane Database Syst Rev; 2009 Jan 21; (1):CD000141. PubMed ID: 19160177
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Serial phospholipid analysis in preterm infants: comparison of Exosurf and Survanta.
    Lloyd J, Todd DA, John E.
    Early Hum Dev; 1999 Mar 21; 54(2):157-68. PubMed ID: 10213294
    [Abstract] [Full Text] [Related]

  • 28. Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials.
    Zhang L, Cao HY, Zhao S, Yuan LJ, Han D, Jiang H, Wu S, Wu HM.
    Pulm Pharmacol Ther; 2015 Oct 21; 34():46-54. PubMed ID: 26296793
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants.
    Ramanathan R, Rasmussen MR, Gerstmann DR, Finer N, Sekar K, North American Study Group.
    Am J Perinatol; 2004 Apr 21; 21(3):109-19. PubMed ID: 15085492
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Surfactant and respiratory distress syndrome.
    Milner AD.
    Turk J Pediatr; 1996 Apr 21; 38(1):37-43. PubMed ID: 8819619
    [Abstract] [Full Text] [Related]

  • 40. Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome.
    Fujii AM, Patel SM, Allen R, Doros G, Guo CY, Testa S.
    J Perinatol; 2010 Oct 21; 30(10):665-70. PubMed ID: 20336076
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.